WX [WuXi PharmaTech (Cayman)] SC 13E3/A: PROXY STATEMENT OF THE COMPANY October 20, 2015

[PROXY STATEMENT OF THE COMPANY October 20, 2015 Shareholders of WuXi PharmaTech (Cayman) Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of WuXi PharmaTech (Cayman) Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), to be held] [EXECUTION VERSION SECOND AMENDED AND RESTATED CONSORTIUM AGREEMENT THIS SECOND AMENDED AND RESTATED CONSORTIUM AGREEMENT Agreement Chairman ABG Boyu Initial Sponsors G&C Temasek Hillhouse PRC Ping An G&C IV Co-Founder Equity LP Yunfeng Sequoia Legend Capital SPDBI Principal Consortium Member Principal Consortium Members Party Sponsor Parties Sponsors WHEREAS Original Consortium Agreement Transaction Company NYSE Exchange Act WHEREAS A&R Consortium Agreement] [EXECUTION VERSION CONFIDENTIAL AMENDED AND RESTATED INTERIM INVESTORS AGREEMENT Agreement Chairman Management Roll-over Entity ABG Boyu Temasek Hillhouse Ping An G&C IV Co-Founder Equity LP Yunfeng Sequoia Legend Capital SPDBI Equity Sponsor Equity Sponsors Investor Investors Holdco Parent Merger Sub Parties Party This Amended and Restated Interim Investors Agreement (this “ RECITALS Original Interim Investors Agreement WHEREAS, on August 14,] []

By | 2016-03-24T01:53:20+00:00 October 20th, 2015|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] CORRESP: (Original Filing)

[787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 VIA EDGAR October 9, 2015 100 F Street, N.E. Attn: David L. Orlic, Special Counsel Office of Mergers and Acquisitions Re: WuXi PharmaTech (Cayman) Inc. Amendment No. 1 to Schedule 13E-3 By WuXi PharmaTech (Cayman) Inc., New WuXi Life Science Holdings Limited, New WuXi Life]

By | 2016-03-24T01:54:56+00:00 October 9th, 2015|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] CORRESP: 787 Seventh Avenue New York, NY 10019-6099 Tel:

[787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 VIA EDGAR October 9, 2015 100 F Street, N.E. Attn: David L. Orlic, Special Counsel Office of Mergers and Acquisitions Re: WuXi PharmaTech (Cayman) Inc. Amendment No. 1 to Schedule 13E-3 By WuXi PharmaTech (Cayman) Inc., New WuXi Life Science Holdings Limited, New WuXi Life]

By | 2016-03-24T01:56:08+00:00 October 9th, 2015|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] SC 13E3/A: (Original Filing)

[PRELIMINARY PROXY STATEMENT OF THE COMPANY [ ], 2015 Shareholders of WuXi PharmaTech (Cayman) Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of WuXi PharmaTech (Cayman) Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), to be] []

By | 2016-03-24T01:57:25+00:00 October 9th, 2015|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] SC 13E3/A: PRELIMINARY PROXY STATEMENT OF THE COMPANY [ ],

[PRELIMINARY PROXY STATEMENT OF THE COMPANY [ ], 2015 Shareholders of WuXi PharmaTech (Cayman) Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of WuXi PharmaTech (Cayman) Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), to be] []

By | 2016-03-24T01:58:44+00:00 October 9th, 2015|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] SC 13G/A: (Original Filing)

[Item 1: Reporting Person - FIL Limited Item 2: (a) [ ] (b) [ ] Item 4: Bermuda Item 5: 26,619,376 Item 6: 0 Item 7: 27,432,304 Item 8: 0 Item 9: 27,432,304 Item 11: 4.825% Item 12: FI Cusip #G98079109 Item 1: Reporting Person - Pandanus Partners, L.P. Item 2: (a) [ ] (b) [ ] Item 4: Delaware]

By | 2016-03-24T01:59:55+00:00 October 2nd, 2015|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments

WX [WuXi PharmaTech (Cayman)] SC 13G/A: Item 1: Reporting Person – FIL Limited Item

[Item 1: Reporting Person - FIL Limited Item 2: (a) [ ] (b) [ ] Item 4: Bermuda Item 5: 26,619,376 Item 6: 0 Item 7: 27,432,304 Item 8: 0 Item 9: 27,432,304 Item 11: 4.825% Item 12: FI Cusip #G98079109 Item 1: Reporting Person - Pandanus Partners, L.P. Item 2: (a) [ ] (b) [ ] Item 4: Delaware]

By | 2016-03-24T02:02:07+00:00 October 2nd, 2015|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments
Skip to toolbar